Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia.
Carlo B Gambacorti-PasseriniFranck Emmanuel NicoliniRichard A LarsonAndrea AroldiDiletta FontanaRocco PiazzaPhilipp le CoutreLaura AntoliniSarit AssoulinePublished in: American journal of hematology (2022)